Gene: EXOC6B
Official Full Name: exocyst complex component 6Bprovided by HGNC
Gene Summary: This gene encodes a protein which is a part of the evolutionarily conserved exocyst, a multimeric protein complex necessary for exocytosis, which in turn, is crucial for cell growth, polarity and migration. Disruption of this gene may be associated with phenotypes exhibiting multiple symptoms including intellectual disability and developmental delay (DD). [provided by RefSeq, Jun 2016]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO29659 | EXOC6B Knockout cell line (HeLa) | Human | EXOC6B | 1:3~1:6 | Negative | Online Inquiry |
KO29660 | EXOC6B Knockout cell line (HCT 116) | Human | EXOC6B | 1:2~1:4 | Negative | Online Inquiry |
KO29661 | EXOC6B Knockout cell line (HEK293) | Human | EXOC6B | 1:3~1:6 | Negative | Online Inquiry |
KO29662 | EXOC6B Knockout cell line (A549) | Human | EXOC6B | 1:3~1:4 | Negative | Online Inquiry |
EXOC6B Gene Knockout Cell Lines are genetically modified cell lines specifically designed to silence the expression of the EXOC6B gene. This gene is associated with the regulation of exocytic transport mechanisms, which are critical for the secretion of proteins and other molecules from cells. By employing advanced CRISPR/Cas9 technology, these cell lines enable researchers to explore the biological functions of EXOC6B, providing insights into its role in various cellular processes including vesicle trafficking, cytokine secretion, and cellular response to external stimuli.
The key function of EXOC6B Gene Knockout Cell Lines lies in their ability to effectively disrupt the normal signaling pathways mediated by the EXOC6B gene, allowing for the study of its impact on cellular physiology and pathology. Researchers can utilize these cell lines to investigate the gene's involvement in diseases such as cancer, neurodegenerative disorders, and other conditions where exocytosis plays a pivotal role. The precise knockout of the EXOC6B gene offers a valuable tool for functional genomics, enabling the assessment of gene function in a controlled environment.
In the academic and clinical research landscapes, the scientific importance of our EXOC6B Gene Knockout Cell Lines cannot be overstated. They facilitate targeted studies that elucidate the underlying mechanisms of disease, aiding in the identification of potential therapeutic targets. Compared to conventional gene silencing techniques, such as RNA interference (RNAi), our knockout cell lines provide a more permanent and robust means of gene disruption, which can lead to more reproducible and clearer results.
What sets our EXOC6B Gene Knockout Cell Lines apart from alternatives is their specificity, reliability, and ease of use. We offer user-friendly protocols and comprehensive support while ensuring that the knockout efficiency is validated through genomic and protein analysis. This level of assurance of quality makes our product a preferred choice for researchers seeking accurate models for their investigations.
Our commitment to cutting-edge technology and excellence in scientific products positions us as a leader in gene editing solutions. With our extensive expertise and dedication to supporting the scientific community, we are proud to provide researchers and clinicians with the tools they need to make significant advancements in their fields.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.